Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Product sales, net $ 16,004,000 $ 16,205,000
Cost of goods sold 8,919,000 10,655,000
Gross profit 7,085,000 5,550,000
Operating expenses:    
Research and development 151,000 307,000
Selling, general and administrative 9,745,000 12,090,000
Benefit from reversal of accrued payroll taxes (Note 13) (6,171,000) 0
Total operating expenses 3,725,000 12,397,000
Operating income (loss) 3,360,000 (6,847,000)
Gain on debt extinguishment 0 (127,000)
Other expense, net 264,000 1,541,000
Income (loss) before income taxes 3,096,000 (8,261,000)
Income tax benefit (6,000) (47,000)
Net income (loss) 3,102,000 (8,214,000)
Deemed dividend for beneficial conversion of Series A Convertible Preferred Stock 0 920,000
Net income (loss) attributable to common stockholders 3,102,000 (9,134,000)
Net income (loss) attributable to common stockholders $ 3,102,000 $ (9,134,000)
Weighted average common shares outstanding    
Basic 153,954 138,034
Diluted 153,955 138,034
Net income (loss) per share attributable to common stockholders    
Basic $ 0.02 $ (0.07)
Diluted $ 0.02 $ (0.07)
Revenue, Product and Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember